Jorge Zerón-Medina

1.6k total citations
16 papers, 436 citations indexed

About

Jorge Zerón-Medina is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jorge Zerón-Medina has authored 16 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Jorge Zerón-Medina's work include Cancer-related Molecular Pathways (4 papers), Epigenetics and DNA Methylation (3 papers) and Cancer Genomics and Diagnostics (3 papers). Jorge Zerón-Medina is often cited by papers focused on Cancer-related Molecular Pathways (4 papers), Epigenetics and DNA Methylation (3 papers) and Cancer Genomics and Diagnostics (3 papers). Jorge Zerón-Medina collaborates with scholars based in United Kingdom, Spain and Mexico. Jorge Zerón-Medina's co-authors include Gareth L. Bond, Sophie B. Mériaux, Lukasz F. Grochola, Ian Tomlinson, Douglas A. Bell, Francesc Castro-Giner, Xuting Wang, Sarah De Val, Elisabeth F.P. Peterse and Graeme J. Walker and has published in prestigious journals such as Cell, Nature reviews. Cancer and JNCI Journal of the National Cancer Institute.

In The Last Decade

Jorge Zerón-Medina

16 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jorge Zerón-Medina United Kingdom 9 267 173 113 68 55 16 436
Ulrike Hopfer Germany 9 288 1.1× 112 0.6× 172 1.5× 54 0.8× 66 1.2× 11 532
Hyewon Park South Korea 13 312 1.2× 182 1.1× 72 0.6× 45 0.7× 62 1.1× 28 523
Esra Dikoglu United States 10 232 0.9× 111 0.6× 70 0.6× 36 0.5× 80 1.5× 14 402
Kimihiro Tanaka Japan 12 228 0.9× 211 1.2× 154 1.4× 34 0.5× 73 1.3× 51 530
Michael Wirtenberger Germany 11 232 0.9× 129 0.7× 56 0.5× 40 0.6× 103 1.9× 14 393
C. Rimkus Germany 5 169 0.6× 148 0.9× 55 0.5× 35 0.5× 27 0.5× 10 365
Yong Gu China 10 324 1.2× 100 0.6× 181 1.6× 40 0.6× 22 0.4× 14 469
Miyuki Kurai Japan 9 215 0.8× 130 0.8× 76 0.7× 61 0.9× 65 1.2× 10 424
Songwang Cai China 13 315 1.2× 154 0.9× 186 1.6× 34 0.5× 14 0.3× 33 516
Jue‐Yu Zhou China 15 426 1.6× 110 0.6× 278 2.5× 29 0.4× 34 0.6× 42 591

Countries citing papers authored by Jorge Zerón-Medina

Since Specialization
Citations

This map shows the geographic impact of Jorge Zerón-Medina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorge Zerón-Medina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorge Zerón-Medina more than expected).

Fields of papers citing papers by Jorge Zerón-Medina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorge Zerón-Medina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorge Zerón-Medina. The network helps show where Jorge Zerón-Medina may publish in the future.

Co-authorship network of co-authors of Jorge Zerón-Medina

This figure shows the co-authorship network connecting the top 25 collaborators of Jorge Zerón-Medina. A scholar is included among the top collaborators of Jorge Zerón-Medina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorge Zerón-Medina. Jorge Zerón-Medina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Hamilton, Erika, Judy S. Wang, Amit M. Oza, et al.. (2023). First-in-human Study of AZD5153, A Small-molecule Inhibitor of Bromodomain Protein 4, in Patients with Relapsed/Refractory Malignant Solid Tumors and Lymphoma. Molecular Cancer Therapeutics. 22(10). 1154–1165. 14 indexed citations
2.
Carneiro, Benedito A., Maria Diab, Brian Andrew Van Tine, et al.. (2023). Abstract CT116: First-in-human study of AZD8853, an anti-growth and differentiation factor 15 (GDF15) antibody, in patients (pts) with advanced/metastatic solid tumors. Cancer Research. 83(8_Supplement). CT116–CT116. 3 indexed citations
3.
Cedrés, S., Enriqueta Felip, Cristina Cruz, et al.. (2018). Activity of HSP90 Inhibiton in a Metastatic Lung Cancer Patient With a Germline BRCA1 Mutation. JNCI Journal of the National Cancer Institute. 110(8). 914–917. 14 indexed citations
4.
Carcereny, Enric, José Luís Mate, Núria Pardo, et al.. (2017). P1.05-015 Major Pathological Response as a Predictive Value of Survival in Early-Stage NSCLC After Chemotherapy: Cohort of NATCH Phase III Trial. Journal of Thoracic Oncology. 12(11). S1983–S1983. 1 indexed citations
5.
Allende, M.T., Jorge Zerón-Medina, Javier Hernández‐Losa, et al.. (2017). Overexpression of Yes Associated Protein 1, an Independent Prognostic Marker in Patients With Pancreatic Ductal Adenocarcinoma, Correlated With Liver Metastasis and Poor Prognosis. Pancreas. 46(7). 913–920. 51 indexed citations
6.
Stracquadanio, Giovanni, Xuting Wang, Marsha D. Wallace, et al.. (2016). The importance of p53 pathway genetics in inherited and somatic cancer genomes. Nature reviews. Cancer. 16(4). 251–265. 101 indexed citations
7.
Zerón-Medina, Jorge, María Ochoa de Olza, Irene Braña, & Jordi Rodón. (2015). The Personalization of Therapy: Molecular Profiling Technologies and Their Application. Seminars in Oncology. 42(6). 775–787. 4 indexed citations
8.
Lewis, Annabelle, Luke Freeman-Mills, Elisa de la Calle‐Mustienes, et al.. (2014). A Polymorphic Enhancer near GREM1 Influences Bowel Cancer Risk through Differential CDX2 and TCF7L2 Binding. Cell Reports. 8(4). 983–990. 34 indexed citations
9.
Zerón-Medina, Jorge, Xuting Wang, Emmanouela Repapi, et al.. (2013). A Polymorphic p53 Response Element in KIT Ligand Influences Cancer Risk and Has Undergone Natural Selection. Cell. 155(2). 410–422. 96 indexed citations
10.
Finlayson, Alexander, et al.. (2011). Post 9/11 Somalia: the strategic role of health systems strengthening in global security. Medicine Conflict & Survival. 27(4). 205–210. 2 indexed citations
11.
Zerón-Medina, Jorge, et al.. (2011). Solitary Fibrous Tumor of the Pelvis Treated with Preoperative Embolization and Pelvic Exenteration. The American Surgeon. 77(1). 112–113. 5 indexed citations
12.
Grochola, Lukasz F., Jorge Zerón-Medina, Sophie B. Mériaux, & Gareth L. Bond. (2009). Single-nucleotide Polymorphisms in the p53 Signaling Pathway. Cold Spring Harbor Perspectives in Biology. 2(5). a001032–a001032. 81 indexed citations
13.
Medina‐Franco, Heriberto, Noel Salgado‐Nesme, & Jorge Zerón-Medina. (2009). Sentinel lymph node biopsy after neoadjuvant systemic chemotherapy in patients with breast cancer: a prospective pilot trial.. PubMed. 60(5). 390–4. 3 indexed citations
14.
Vergara‐Fernández, Omar, Jorge Zerón-Medina, Noel Salgado‐Nesme, et al.. (2009). Acute Abdominal Pain in Patients with Systemic Lupus Erythematosus. Journal of Gastrointestinal Surgery. 13(7). 1351–1357. 10 indexed citations
15.
Alexánderson, Erick, et al.. (2007). Transient perfusion and motion abnormalities in takotsubo cardiomyopathy. Journal of Nuclear Cardiology. 14(1). 129–133. 16 indexed citations
16.
Alexánderson, Erick, et al.. (2007). [Discordant pattern, visual identification of myocardial viability with PET].. PubMed. 76(4). 347–54. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ulrike Hopfer Breakdown of academic impact, for papers by Hyewon Park Breakdown of academic impact, for papers by Esra Dikoglu Breakdown of academic impact, for papers by Kimihiro Tanaka Breakdown of academic impact, for papers by Michael Wirtenberger Breakdown of academic impact, for papers by C. Rimkus Breakdown of academic impact, for papers by Yong Gu Breakdown of academic impact, for papers by Miyuki Kurai Breakdown of academic impact, for papers by Songwang Cai Breakdown of academic impact, for papers by Jue‐Yu Zhou
Rankless by CCL
2026